Transplant Diagnostics: The Global Market to 2024 with Profiles for Thermo Fisher Scientific, Qiagen, Illumina, F. Hoffman La-Roche, Abbott, Bio-Rad Labs, Immucor, and Omixon - ResearchAndMarkets.com

August 31, 2018

DUBLIN--(BUSINESS WIRE)--Aug 31, 2018--The “Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 - 2024” report has been added to ResearchAndMarkets.com’s offering.

The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024 It is projected to expand at a CAGR of 7.6% over the forecast period.

Increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Key Findings

PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase

Key Topics Covered

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Transplant Diagnostics Market Variables, Trends & Scope

Chapter 4 Transplant Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 5 Transplant Diagnostics Market: Product Estimates & Trend Analysis

Chapter 6 Transplant Diagnostic Market: Regional Estimates & Trend Analysis, by Technology & Product Type

Chapter 7 Competitive Landscape - Company Profiles

Thermo Fisher Scientific Inc. QIAGEN Illumina Inc. F. Hoffmann La-Roche Ltd. Abbott Bio-Rad Laboratories Inc. IMMUCOR Omixon Inc.

For more information about this report visit https://www.researchandmarkets.com/research/jplc64/transplant?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180831005156/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/31/2018 07:29 AM/DISC: 08/31/2018 07:29 AM


Update hourly